Abstract Leadless pacemaker implantation represents an emerging therapeutic alternative for patients ineligible for conventional pacing systems; nevertheless, clinical experience in young children remains scarce. Individuals with 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) are susceptible to conduction abnormalities and severe hypersensitivity reactions to transvenous pacing devices.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Kaili
Contact Kaili, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack